Cargando…
Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review)
As early as 50 years ago, bisphosphonates turned from a water treatment agent into one of the most widely used groups of drugs for the treatment of various diseases of calcium metabolism (bone tissue resorption, oncological complications of neurodegenerative diseases and others). Years of research o...
Autor principal: | Timchenko, T.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Privolzhsky Research Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090926/ https://www.ncbi.nlm.nih.gov/pubmed/37065429 http://dx.doi.org/10.17691/stm2022.14.2.07 |
Ejemplares similares
-
Immobilized Bisphosphonates as Potential Inhibitors of Bioprosthetic Calcification: Effects on Various Xenogeneic Cardiovascular Tissues
por: Zhuravleva, Irina Y., et al.
Publicado: (2021) -
Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
por: Meng, Zhen, et al.
Publicado: (2021) -
Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification
por: Wen, Shuyu, et al.
Publicado: (2022) -
Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction
por: Lee, Suengwon, et al.
Publicado: (2017) -
Early bioprosthetic valve calcification with alfacalcidol supplementation
por: Takano, Tamaki, et al.
Publicado: (2013)